PMGC Holdings (ELAB) EBT Margin (2022 - 2026)
PMGC Holdings (ELAB) posted EBT Margin of 889.64% for Q1 2026, down 0.85% sequentially from 882.11% in Q4 2025, and down 96273.0% YoY from N/an in Q1 2025.
PMGC Holdings (ELAB) EBT Margin (2022 - 2026) Analysis & Trends
PMGC Holdings has reported EBT Margin for 5 years, with the latest figure at 889.64% in Q1 2026.
- Quarterly EBT Margin fell 96273.0% year-over-year to 889.64% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 948.16% (down 86818.0% YoY) and the FY2025 annual result came in at 1415.72%, up 117047.0% from the prior year.
- EBT Margin slipped to 889.64% in Q1 2026 per ELAB's latest filing, from 882.11% in the prior quarter.
- Over five years, EBT Margin peaked at 200.93% in Q4 2024 and troughed at 48736.78% in Q3 2023.
- A 5-year average of 3830.34% and a median of 304.38% in 2024 frame the typical range for EBT Margin.
- The sharpest annual moves came in 2023 and 2024: EBT Margin sank 4862818 bps in 2023, then surged 4843264 bps in 2024.
- Over 5 years, EBT Margin stood at 177.86% in 2022, then climbed by 13 bps to 154.95% in 2023, then jumped by 230 bps to 200.93% in 2024, then plunged by 539 bps to 882.11% in 2025, then retreated by 1 bps to 889.64% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 889.64%, 882.11%, and 1157.97% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 35.71% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -528.97% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 18.33% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 13.77% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -2.67% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 12.09% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -25.06% |
| 10 | PMGC Holdings | 3.01 Mn | -15.78 Mn | 385,691.00 | -331.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -889.64% |
| Dec 31, 2025 | -882.11% |
| Sep 30, 2025 | -1,157.97% |
| Mar 31, 2025 | 73.09% |
| Dec 31, 2024 | 200.93% |
| Sep 30, 2024 | -304.15% |
| Jun 30, 2024 | -257.10% |
| Mar 31, 2024 | -304.61% |
| Dec 31, 2023 | -154.95% |
| Sep 30, 2023 | -48,736.78% |
| Jun 30, 2023 | -334.06% |
| Mar 31, 2023 | -590.90% |
| Dec 31, 2022 | -177.86% |
| Sep 30, 2022 | -108.61% |